STIM:NASDAQ
Neuronetics Inc
$1.91
arrow_upward
+1.33%(+0.025) 1D
Oct 19, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for STIM...
Open
$1.88
High
$1.94
Low
$1.85
Mkt. cap
145.15M
Avg. vol.
1.11M
Volume
559.15K
52-wk high
$3.44
52-wk low
$0.80
EPS
-$0.44
Beta
1.19
Shares outstanding
76.20M
No. of employees
658
Open
$1.88
High
$1.94
Low
$1.85
Mkt. cap
145.15M
Avg. vol.
1.11M
Volume
559.15K
52-wk high
$3.44
52-wk low
$0.80
EPS
-$0.44
Beta
1.19
Shares outstanding
76.20M
No. of employees
658
News stories
From web sources and news partners
TheStreet
·
1 hour ago
Sam Stovall’s S&P 500 outlook offers hope for 2027
Investing.com
·
4 hours ago
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.07%
TradingView
·
5 hours ago
There is no fundamental reason for stocks’ reversal, says SA analyst
BigGo Finance
·
1 hour ago
Chip Stocks Rebound; Nasdaq Gains 1.1%, Dow Slips 36 Points
Profile
Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology.
Neuronetics became the "first and only Food and Drug Administration approval for the clinical treatment of a specific form of medication-refractory depression using a TMS Therapy device."
They manufacture a transcranial magnetic stimulation device, NeuroStar. The NeuroStar TMS therapy is delivered via a precisely positioned magnetic coil against the patient's head. Wikipedia
About Neuronetics Inc
CEO-
Employees658
Founded2003
HeadquartersMalvern, Pennsylvania, United States
SectorMedical device
Websiteneurostar.com